Answers are grounded in this paper and cite their sources.
Background Vancomycin dosing during intermittent hemodialysis is challenging, and access to therapeutic drug monitoring and area-under-the-curve-based dosing may be limited in resource-constrained dialysis settings. Prospective evidence on vancomycin exposure in African hemodialysis populations remains scarce. We evaluated predialysis concentrations achieved after 500- and 1000-mg post-hemodialysis dosing at a Kenyan tertiary hospital. Methods We conducted a prospective, single-centre observational study among adults receiving maintenance hemodialysis and empirical intravenous vancomycin for suspected catheter-related bloodstream infection. Participants received a post-hemodialysis dose of 500 mg or 1000 mg, as prescribed by the treating clinicians as part of routine care. Predialysis vancomycin concentrations were measured at study-designated 2-day and 3-day interdialytic intervals. Concentrations were classified relative to a study-defined reference range of 15–20 mg/L. Attainment, within-participant change, differences between dose groups, and exploratory associations with participant characteristics were evaluated. Culture results, including the organisms isolated, were summarised descriptively. Results Eighteen participants were enrolled, and 17 had evaluable concentration measurements. Mean predialysis concentrations were 8.51 mg/L (SD 5.19) and 9.52 mg/L (SD 6.04) at the 2-day and 3-day measurements, respectively. Fourteen of 17 participants (82.4%) had concentrations below 15 mg/L at each measurement, and one participant (5.9%) was within the 15–20 mg/L range at both measurements. The median paired change was + 0.60 mg/L (IQR 0.00–1.50; P = 0.002). Body weight was not associated with patient-mean concentration (Spearman ρ = 0.023; P = 0.931), and concentrations did not differ detectably between the 500- and 1000-mg groups (P = 0.397). Organisms were isolated from 12/18 participants (66.7%), all with at least one Gram-positive organism; Staphylococcus aureus was the most frequent isolate (7/18, 38.9%), and six of the seven evaluable participants with S. aureus had patient mean predialysis concentrations below 15 mg/L. Conclusions Fixed post-hemodialysis dosing frequently resulted in predialysis vancomycin concentrations below the study-defined reference range, while occasional above-range concentrations demonstrated substantial interindividual variability. Because S. aureus predominated among culture-positive participants, sustained subtherapeutic exposure is of concern not only for treatment failure but also for the selection of strains with reduced vancomycin susceptibility in hemodialysis patients. These findings support prospective evaluation of feasible concentration-guided dosing strategies for hemodialysis programmes where more sophisticated pharmacokinetic monitoring is not routinely available.
No takes yet. Share an insight, caveat, or question.
Lubomba et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: